Clinical trial
A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)
NCT06281236 is registered in ClinicalTrials.gov with Sparrow Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)
- Lead sponsor
- Sparrow Pharmaceuticals
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- February 22, 2022
- Completion date
- April 25, 2025
- Enrollment
- 1 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.